回复：达比加群或华法林治疗的亚洲房颤患者的死亡率和急性肾损伤 - Suppr

Suppr

超能文献

Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

作者信息

Chan Yi-Hsin, Kuo Chi-Tai

出版信息

J Am Coll Cardiol. 2017 May 16;69(19):2471-2472. doi: 10.1016/j.jacc.2017.02.061.

DOI:10.1016/j.jacc.2017.02.061

PMID:28494990

Abstract

摘要

相似文献

Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2017 May 16;69(19):2471-2472. doi: 10.1016/j.jacc.2017.02.061.

Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2017 May 16;69(19):2471. doi: 10.1016/j.jacc.2017.01.071.

Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2016 Nov 29;68(21):2272-2283. doi: 10.1016/j.jacc.2016.08.063.

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.

BMJ. 2015 Apr 24;350:h1857. doi: 10.1136/bmj.h1857.

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.

Circulation. 2015 Jan 13;131(2):157-64. doi: 10.1161/CIRCULATIONAHA.114.012061. Epub 2014 Oct 30.

Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.

Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4). doi: 10.1161/CIRCOUTCOMES.116.003418.

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.

Stroke. 2017 Apr;48(4):970-976. doi: 10.1161/STROKEAHA.116.016275. Epub 2017 Feb 17.

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.

J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.

Stroke. 2017 Jan;48(1):159-166. doi: 10.1161/STROKEAHA.116.015150. Epub 2016 Dec 1.

引用本文的文献

Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study.

Clin Kidney J. 2023 Oct 3;17(1):sfad252. doi: 10.1093/ckj/sfad252. eCollection 2024 Jan.

Prevalence and risk factors for myopia in Taiwanese diabetes mellitus patients: a multicenter case-control study in Taiwan.

Sci Rep. 2021 Apr 14;11(1):8195. doi: 10.1038/s41598-021-87499-y.

Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.

Postepy Kardiol Interwencyjnej. 2019;15(1):59-67. doi: 10.5114/aic.2019.83772. Epub 2019 Apr 4.

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Nat Rev Nephrol. 2018 May;14(5):337-351. doi: 10.1038/nrneph.2018.19. Epub 2018 Mar 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

作者信息

Chan Yi-Hsin, Kuo Chi-Tai

出版信息

J Am Coll Cardiol. 2017 May 16;69(19):2471-2472. doi: 10.1016/j.jacc.2017.02.061.

DOI:10.1016/j.jacc.2017.02.061

PMID:28494990

Abstract

摘要

相似文献

Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2017 May 16;69(19):2471-2472. doi: 10.1016/j.jacc.2017.02.061.

Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2017 May 16;69(19):2471. doi: 10.1016/j.jacc.2017.01.071.

Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.

J Am Coll Cardiol. 2016 Nov 29;68(21):2272-2283. doi: 10.1016/j.jacc.2016.08.063.

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.

BMJ. 2015 Apr 24;350:h1857. doi: 10.1136/bmj.h1857.

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.

Circulation. 2015 Jan 13;131(2):157-64. doi: 10.1161/CIRCULATIONAHA.114.012061. Epub 2014 Oct 30.

Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.

Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4). doi: 10.1161/CIRCOUTCOMES.116.003418.

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.

Stroke. 2017 Apr;48(4):970-976. doi: 10.1161/STROKEAHA.116.016275. Epub 2017 Feb 17.

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.

J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.

Stroke. 2017 Jan;48(1):159-166. doi: 10.1161/STROKEAHA.116.015150. Epub 2016 Dec 1.

引用本文的文献

Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study.

Clin Kidney J. 2023 Oct 3;17(1):sfad252. doi: 10.1093/ckj/sfad252. eCollection 2024 Jan.

Prevalence and risk factors for myopia in Taiwanese diabetes mellitus patients: a multicenter case-control study in Taiwan.

Sci Rep. 2021 Apr 14;11(1):8195. doi: 10.1038/s41598-021-87499-y.

Postepy Kardiol Interwencyjnej. 2019;15(1):59-67. doi: 10.5114/aic.2019.83772. Epub 2019 Apr 4.

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Nat Rev Nephrol. 2018 May;14(5):337-351. doi: 10.1038/nrneph.2018.19. Epub 2018 Mar 26.